Targeted Cancer Treatment: Plus Therapeutics CEO Marc Hedrick, Live from NYSE
Healthcare Edge hosted a fireside chat from the floor of the New York Stock Exchange with Marc Hedrick, M.D., President and CEO of Plus Therapeutics, Inc. (Nasdaq: PSTV). Dr. Hedrick spoke to Healthcare Edge Editor-in-Chief John Jannarone about its novel targeted radio-therapeutics treatment for central nervous system cancer using the latest technology, its future potential […]
University Of Texas Southwestern Medical School United States San Antonio Anderson School Los Angeles John Jannarone
Source: yahoo.com